Neuronetics Cash Flow from Operating Activities 2017-2024 | STIM
Neuronetics cash flow from operating activities from 2017 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Neuronetics Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $-31 |
| 2023 | $-32 |
| 2022 | $-31 |
| 2021 | $-28 |
| 2020 | $-28 |
| 2019 | $-30 |
| 2018 | $-21 |
| 2017 | $-11 |
| 2016 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.301B | $0.075B |
| Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States. | |||